The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 23, 2018
Filed:
Jun. 08, 2016
Applicant:
Abbvie Inc., North Chicago, IL (US);
Inventors:
Maria A. Argiriadi, Southborough, MA (US);
Eric C. Breinlinger, Charlton, MA (US);
Kevin P. Cusack, Holden, MA (US);
Adrian D. Hobson, Shrewsbury, MA (US);
Dominique Potin, Talant, FR;
Martine Barth, Asniéres les Dijon, FR;
Jerome Amaudrut, Dijon, FR;
Olivia Poupardin, Varios es Chaignot, FR;
Laurent Mounier, Marsannay le Bois, FR;
Michael E. Kort, Lake Bluff, IL (US);
Assignee:
AbbVie Inc., North Chicago, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 209/08 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01); C07D 401/06 (2006.01); C07D 491/107 (2006.01); C07D 405/14 (2006.01); C07D 235/06 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 231/56 (2006.01); C07D 235/16 (2006.01); C07D 405/10 (2006.01); C07D 491/10 (2006.01); C07D 209/14 (2006.01); C07D 209/18 (2006.01);
U.S. Cl.
CPC ...
C07D 209/08 (2013.01); C07D 209/14 (2013.01); C07D 209/18 (2013.01); C07D 231/56 (2013.01); C07D 235/06 (2013.01); C07D 235/16 (2013.01); C07D 401/06 (2013.01); C07D 401/10 (2013.01); C07D 401/14 (2013.01); C07D 403/10 (2013.01); C07D 405/10 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/10 (2013.01); C07D 491/107 (2013.01);
Abstract
The invention provides compounds of Formula (I) pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.